Lada Svobodova

Dr. Lada Svobodova

Technical University of Liberec, Liberec, Liberecký Kraj, Czech Republic
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MNMarek Novak
Marek Novak
JRJozef Rosina
Jozef Rosina
HBHana Bendová
Hana Bendová
KKKristina Kejlová
Kristina Kejlová
AVAlena Vlková
Alena Vlková
JHJan Hajer
Jan Hajer
The research of novel implantable medical devices is one of the most attractive, yet complex areas in the biomedical field. The design and development of sufficiently small devices working in an in vivo environment is challenging but successful encapsulation of such devices is even more so. Industry-standard methods using glass and titanium are too expensive and tedious, and epoxy or silicone encapsulation is prone to water ingress with cable feedthroughs being the most frequent point of failure. This paper describes a universal and straightforward method for reliable encapsulation of circuit boards that achieves ISO10993 compliance. A two-part PVDF mold was machined using a conventional 3-axis machining center. Then, the circuit board with a hermetic feedthrough was placed in the mold and epoxy resin was injected into the mold under pressure to fill the cavity. Finally, the biocompatibility was further enhanced with an inert P3HT polymer coating which can be easily formulated into an ink. The biocompatibility of the encapsulants was assessed according to ISO10993. The endurance of the presented solution compared to silicone potting and epoxy potting was assessed by submersion in phosphate-buffered saline solution at 37 °C. The proposed method showed superior results to PDMS and simple epoxy potting.

1 January 2021 in ALTEX
Verified
Journal Article
Open access
PDF file
LSLada Svobodova
Lada Svobodova
MRMarian Rucki
Marian Rucki
AVAlena Vlkova
Alena Vlkova
KKKristina Kejlova
Kristina Kejlova
DJDagmar Jírová
Dagmar Jírová
MMMarek Maly
Marek Maly
Medical devices have to be tested before marketing in accordance with ISO EN 10993-10 in order to avoid skin sensitization. This standard predominantly refers to the in vivo test; however, it doesn't exclude the use of in vitro methods, which have been sufficiently technically and scientifically validated for the purpose of medical devices testing. It is foreseen that due to the complexity of the sensitization endpoint, combination of several methods will be needed to address all key events occurring in the sensitization process. The objective of this pilot study was to evaluate sensitization potential of selected medical devices using a combination of in vitro (LuSens, OECD TG 442D), in chemico (DPRA, OECD TG 442C) and in vivo (LLNA DA, OECD TG 442A) methods and to suggest a possible testing strategy for the safety assessment of medical devices extracts. Overall, one of the 42 tested samples exhibited positive results in all employed test methods, while 33 samples were predicted as samples with non-sensitizing potential in all three performed methods. This study demonstrated good agreement between in vitro and in vivo results regarding the absence of skin sensitization potential; however, discrepancies in positive classification have been recorded. The mismatch between in vitro and in vivo results might be caused by specific response of the immune system of the living organism. The in vitro methods require optimization of procedure, in particular the choice of appropriate extraction vehicle and applied volumes.

21 December 2023 in Journal of Xenobiotics
Verified
Journal Article
Open access
PDF file
JCJan Chrz
Jan Chrz
MDMarketa DVORAKOVA
Marketa DVORAKOVA
KKKristina Kejlová
Kristina Kejlová
DODanuše Očadlíková
Danuše Očadlíková
LSLada Svobodova
Lada Svobodova
HKHana Kolarova
Hana Kolarova
Triclosan and Triclocarban, preservatives widely used in cosmetics and other consumer products, underwent evaluation using a battery of new-approach methodologies in vitro (NAMs). Specifically, the Microplate Ames Test (MPF™ Test, Xenometrix, Allschwil, Switzerland) was employed to assess mutagenicity, the Comet assay in vitro on the HaCat cell line and the Mammalian Chromosome Aberration Test were utilized to evaluate genotoxicity, and the XenoScreen® YES/YAS assay was applied to investigate endocrine disruption. The chemicals did not exhibit any positive responses for mutagenicity. However, the mammalian chromosome aberration test identified both chemicals as being positive for genotoxicity at 10 µg/mL. In the Comet assay, the percentage of DNA in the tail significantly increased in a concentration-dependent manner (at 5 and 10 µg/mL for Triclosan, at 2.5, 5, and 10 µg/mL for Triclocarban). The positive response depended on the increasing concentration and the duration of exposure. Triclosan, but not Triclocarban in any of the endocrine assays performed, indicated a potential for endocrine activity in the anti-estrogenic and anti-androgenic assays. The positive in vitro results detected were obtained for concentrations relevant to final products. The alarming findings obtained with the use of new-approach methodologies (NAMs) justify the current precautionary regulatory approach, limiting the use of these preservatives.

13 October 2022 in Current Research in Toxicology
Verified
Journal Article
Open access
MMMarika Mannerstrom
Marika Mannerstrom
MDMarketa DVORAKOVA
Marketa DVORAKOVA
LSLada Svobodova
Lada Svobodova
MRMarian Rucki
Marian Rucki
FKFilip Kotal
Filip Kotal
THTuula Heinonen
Tuula Heinonen
• New approach methods were used to assess the hazard of indoor air condensates. • Individual chemicals could not be detected in the condensates. • Indoor air hazard was demonstrable in biological assays indicating cumulative effect.

28 June 2023 in Alternatives to Laboratory Animals
Verified
Journal Article
Closed access
MDMarketa DVORAKOVA
Marketa DVORAKOVA
LSLada Svobodova
Lada Svobodova
MRMarian Rucki
Marian Rucki
VŠVáclav Ševčík
Václav Ševčík
BHBarbora Hošíková
Barbora Hošíková
DJDagmar Jírová
Dagmar Jírová
Animal testing has been prohibited for the safety assessment of cosmetic ingredients or finished products. Thus, alternative non-animal methods, followed by confirmatory clinical studies on human volunteers, should be used as the sole legally acceptable approach within the EU. The safety assessment of cosmetic products requires the involvement of multiple scientific disciplines, including analytical chemistry and biomedicine, as well as in chemico, in vitro and in silico toxicology. Recent data suggest that fragrance components may exert multiple adverse biological effects, e.g. cytotoxicity, skin sensitisation, (photo)genotoxicity, mutagenicity, reprotoxicity and endocrine disruption. Therefore, a pilot study was conducted with selected samples of fragrance-based products, such as deodorant, eau de toilette and eau de parfum, with the aim of integrating results from a number of alternative non-animal methods suitable for the detection of the following toxicological endpoints: cytotoxicity (with 3T3 Balb/c fibroblasts); skin sensitisation potential ( in chemico method, DPRA); skin sensitisation potential (LuSens in vitro method, based on human keratinocytes); genotoxicity potential ( in vitro Comet assay with 3T3 Balb/c cells); and endocrine disruption ( in vitro YES/YAS assay). The presence of twenty-four specific known allergens in the products was determined by using GC-MS/MS. The strategies for estimation of the NOAEL of a mixture of allergens, which were proposed by the Scientific Committee on Consumer Products in their ‘Opinion on Tea tree oil’ document and by the Norwegian Food Safety Authority in their 'Risk Profile of Tea tree oil' report, were used as models for the NOAEL estimation of the mixtures of allergens that were identified in the individual samples tested in this study.

1 August 2020 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
KKKristina Kejlová
Kristina Kejlová
HBHana Bendová
Hana Bendová
JCJan Chrz
Jan Chrz
MDMarkéta Dvořáková
Markéta Dvořáková
LSLada Svobodova
Lada Svobodova
HKHana Kolářová
Hana Kolářová